Ting Yang, Yi-Xin Jiang, Ye Wu, Dong Lu, Rui Huang, Long-Ling Wang, . . . Xin Luan. (2021). Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway. Frontiers Media S.A..
Chicago Style (17th ed.) CitationTing Yang, et al. Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationTing Yang, et al. Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway. Frontiers Media S.A., 2021.
Warning: These citations may not always be 100% accurate.